Standout Papers

Trastuzumab emtansine ver... 2017 2026 2020 2023 2017 100 200 300

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 61 hit
Sub-graph 1 of 18

Citing Papers

Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
2025 Hit
Gastric cancer
2025 Hit

Works of Betsy Althaus being referenced

Mosunetuzumab, a Novel CD20/CD3 Bispecific Antibody, in Combination with CHOP Confers High Response Rates in Patients with Diffuse Large B-Cell Lymphoma
2020
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
2017 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Betsy Althaus 536 342 226 108 102 15 674
Keun-Wook Lee 409 0.8× 376 1.1× 111 0.5× 146 1.4× 108 1.1× 12 582
Iris Nagelmeier 520 1.0× 366 1.1× 222 1.0× 83 0.8× 54 0.5× 12 647
Shigekazu Ohoyama 398 0.7× 333 1.0× 192 0.8× 172 1.6× 98 1.0× 13 654
Karen Afenjar 453 0.8× 216 0.6× 166 0.7× 56 0.5× 47 0.5× 15 565
Viktoria S. Warneke 323 0.6× 296 0.9× 67 0.3× 186 1.7× 86 0.8× 15 667
Iveta Kudaba 622 1.2× 483 1.4× 39 0.2× 96 0.9× 87 0.9× 24 738
Svenja Thies 218 0.4× 258 0.8× 51 0.2× 151 1.4× 43 0.4× 16 611
Eduardo Yañez Ruiz 448 0.8× 341 1.0× 32 0.1× 157 1.5× 117 1.1× 12 621
J C Givel 277 0.5× 96 0.3× 108 0.5× 133 1.2× 72 0.7× 19 570
Malinka Jansson 637 1.2× 349 1.0× 48 0.2× 168 1.6× 42 0.4× 11 738

All Works

Loading papers...

Rankless by CCL
2026